Immunohistochemical assessment of cannabinoid type-1 receptor (CB1R) and its correlation with clinicopathological parameters in glioma

BACKGROUND: Glioma is the most frequent primary brain tumor and one of the most aggressive forms of cancer. Recently, numerous studies have focused on cannabinoids as a new therapeutic approach due to their antineoplastic effects through activation of the cannabinoid receptors. This study aimed to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Choucair, Nader, Saker, Zahraa, Eddine, Hassane Kheir, Bahmad, Hisham F., Fares, Youssef, Zaarour, Mariana, Harati, Hayat, Nabha, Sanaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore srl 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248256/
https://www.ncbi.nlm.nih.gov/pubmed/35481563
http://dx.doi.org/10.32074/1591-951X-294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248256/
https://www.ncbi.nlm.nih.gov/pubmed/35481563
http://dx.doi.org/10.32074/1591-951X-294

Ejemplares similares